CRLBF - Cresco Labs Inc.
| Previous Close | 7.34 |
| Open | 7.43 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 7.29 - 7.43 |
| 52 Week Range | 0.81 - 40.63 |
| Volume | 299,463 |
| Avg. Volume | 232,046 |
| Market Cap | 838.505M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Cresco Labs and Origin House Announce Substantial Compliance with HSR Second Request
Cresco Labs Inc. (“Cresco Labs”) (CL.CN) (CRLBF) and CannaRoyalty Corp. d/b/a Origin House (“Origin House” and together with Cresco Labs, the “Companies” – CSE: OH, OTCQX: ORHOF), both announced today that, effective September 16, 2019, they have each submitted certifications of substantial compliance with the request for additional information (“Second Request”) from the United States Department of Justice Antitrust Division (the “DOJ”) in connection with Origin House’s and Cresco Labs’ notification to U.S. antitrust authorities pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”), as amended, in respect of Cresco Labs’ pending acquisition of Origin House (the “Transaction”).
- Business Wire
Cresco Labs to Acquire Tryke Including the Reef Dispensary Portfolio – Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale Capabilities
Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market. Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million 2 . Tryke has established six of the best-positioned retail locations in Nevada and Arizona, including the iconic Reef Dispensary located adjacent to the Las Vegas Strip and five additional operating locations in North Las Vegas, Sparks and Phoenix, AZ.
- CNW Group
Cresco Labs to Acquire Tryke Companies Including the Reef Dispensary Portfolio - Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale Capabilities
Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market. Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million 2. Tryke has established six of the best-positioned retail locations in Nevada and Arizona , including the iconic Reef Dispensary located adjacent to the Las Vegas Strip – which has produced over US$65 million in revenue since 2015 – and five additional operating locations in North Las Vegas , Sparks and Phoenix, AZ.
- Business Wire
Cresco Labs Announces Increased Profitability in Second Quarter 2019 With Revenue Growth of 253% Year-Over-Year and 42% Quarter-Over-Quarter
Conference Call with Investors and Analysts to be Held at 5:00 p.m. Eastern Time Today
- Newsfile
Pre-Earnings Review of Cresco's Operations - Interview with Cresco Labs President Joe Caltabiano
Toronto, Ontario--(Newsfile Corp. - August 20, 2019) - Capital 10X sits down with Cresco Labs (CNSX: CL) President Joe Caltabiano for a pre-earnings review of the multi-state operator's expansion.Cannot view this video? Visit:https://capital10x.com/interview-cresco-labs-joe-caltabiano-pre-earnings-review/Joe talks about the recent Sunnyside* retail rollout, current and future acquisitions, and Cresco Labs' strategy as they continue to grow into one of top U.S. cannabis companies.For more information, please contact:Capital 10XEvan Veryard, President416-571-9037To view the source version of ...
- Business Wire
Cresco Labs Announces Listing on Frankfurt Stock Exchange
“We are pleased to further expand access to Cresco Labs shares with our listing on the Frankfurt Stock Exchange,” said Cresco Labs CEO & Co-Founder Charlie Bachtell. The Frankfurt Stock Exchange is the largest exchange in Germany and one of the largest markets for trading equity securities in the world.
- Business Wire
Illinois Further Accelerates Growth of Medical-use Cannabis Program with Permanent and Expanding Qualifying Conditions Including Chronic Pain
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided comments on the signing into law of legislation that makes Illinois’ medical-use cannabis program permanent, expands the list of qualifying medical conditions, and allows for nurse practitioners and physician’s assistants to certify a patient’s eligibility for the program in addition to doctors. The new law signed by Illinois Governor JB Pritzker on August 12, 2019 takes effect immediately and adds debilitating illnesses such as chronic pain, migraines and irritable bowl syndrome to the list of qualifying medical conditions. Cresco Labs CEO & Co-Founder Charlie Bachtell commented, “We have seen incredible growth in the Illinois medical cannabis program in 2019 with the number of registered patients increasing by more than 50% since the start of the year.
- Business Wire
Cresco Labs Announces Regulatory Approval for Acquisition of One of Ten Vertically Integrated Licenses in New York State
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has received regulatory approval for its acquisition of 100% of the membership interests of Gloucester Street Capital, LLC (“Gloucester”), the parent entity of Valley Agriceuticals, LLC ("Valley Ag") via a merger between Gloucester and an indirect subsidiary of Cresco Labs. Valley Ag holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health.
- Business Wire
Cresco Labs to Report Second Quarter 2019 Financial Results on August 21, 2019
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the second quarter ended June 30, 2019 on Wednesday, August 21, 2019 after the market closes. The Company will hold a conference call and webcast to discuss its business and financial results on Wednesday, August 21, 2019 at 5 p.m. Eastern Time (4 p.m. Central Time). The conference call may be accessed via Cresco Labs’ investor relations website at investors.crescolabs.com or by dialing 866-688-4235 (409-216-0711 for international callers) and providing conference ID 3385937.
- Business Wire
Cresco Labs to Participate in Canaccord Genuity’s 39th Annual Growth Conference
Cresco Labs, Inc. (CL.CN) (CRLBF) (“Cresco” or “the Company”) one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Charlie Bachtell, CEO & Co-Founder, and Joe Caltabiano, President & Co-Founder, will participate in the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019 in Boston. The Company’s presentation is scheduled for 9:30 a.m. ET / 6:30 a.m. PT. Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy.
- CNW Group
Life Science Company Live Investor Presentations Now Available for On-Demand Viewing
Life Science Company Live Investor Presentations Now Available for On-Demand Viewing
- PR Newswire
Life Science Company Live Investor Conference July 11th
Life science company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , July 9, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the ...
- Business Wire
Cresco Labs Updates Illinois Expansion Plan to Serve Adult Use Cannabis Market
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on its Illinois operations following Governor JB Pritzker’s signing into law of the legalization of adult-use cannabis in Illinois beginning on January 1, 2020. “The legalization of adult-use cannabis and the recent expansion of the state’s medical-use program are expected to dramatically increase the consumer base in Illinois and result in annual sales of $2 billion to $4 billion as the market matures,” said Cresco Labs CEO & Co-Founder Charlie Bachtell. “We are making excellent progress on our plans to serve the expanded consumer base, maintain our market leading position in Illinois, and capitalize on the significant growth opportunities available to Cresco.
- Business Wire
Cresco Labs Announces Opening of VidaCann Dispensaries in Pensacola and Jacksonville
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced the opening of new VidaCann medical cannabis dispensaries in the cities of Pensacola and Jacksonville, Florida. With the opening of the new dispensaries, VidaCann now has 12 operating dispensaries throughout the state of Florida.
- Business Wire
Cresco Labs Provides Update on Origin House Acquisition
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on its acquisition (the “Transaction”) of CannaRoyalty Corp. d/b/a Origin House (“Origin House” – CSE: OH, OTCQX: ORHOF). Under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”), Cresco Labs is required to file a notification to U.S. antitrust authorities and observe a waiting period before completing the Transaction.
- PR Newswire
OTC Markets Group Launches OTCQX Cannabis Index
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
- Business Wire
Illinois Passes Legislation Making Medical-Use Cannabis Program Permanent and Expanding Qualifying Conditions
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided comments on the passage of legislation on June 2, 2019 that makes Illinois’ medical-use cannabis program permanent, expands the list of qualifying medical conditions, and allows for nurse practitioners and physician’s assistants to certify a patient’s eligibility for the program in addition to doctors. “The legislation passed this weekend represents the acknowledgement of the enormous success of the pilot medical-use cannabis program put in place in Illinois in 2013,” said Cresco Labs CEO & Co-Founder Charlie Bachtell.
- Business Wire
Illinois Passes Transformative Adult-Use Cannabis Legalization with Sales Starting in January, 2020
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided comments on the legalization of adult-use cannabis in its home state of Illinois. Cresco Labs CEO & Co-Founder Charlie Bachtell served on the Cannabis Legalization Subcommittee of Illinois Governor JB Pritzker’s transition team as the sole representative for cannabis operators in the state. “The legislation passed today legalizing adult-use cannabis in the state of Illinois beginning in 2020 represents a thoughtful expansion of access to cannabis in Illinois and we expect it will have a positive impact on both social justice issues and from a tax revenue perspective by expanding the employment and ownership opportunities for cannabis businesses in the state,” said Mr. Bachtell.